Granted under Issuer's 2005 Equity Incentive Plan.
25% of such shares vest 8/1/2013, and 2.0833% vests monthly thereafter, provided that the Reporting Person continues to be employed by the Issuer.
The above information was disclosed in a filing to the SEC. To see this filing in its entirety, click here.
To receive a free e-mail notification wheneve r SciClone Pharmaceuticals makes a similar move, sign up!